From the Department of Neurology, Wayne State University School of Medicine, Detroit, MI (H.S.).
Department of Neurology (B.B.N., H.K.), Weill Cornell Medical College, New York, NY.
Stroke. 2019 Mar;50(3):683-689. doi: 10.1161/STROKEAHA.118.023967.
Background and Purpose- Recent landmark trials provided overwhelming evidence for effectiveness of endovascular stroke therapy (EST). Yet, the impact of these trials on clinical practice and effectiveness of EST among lower volume centers remains poorly characterized. Here, we determine population-level patterns in EST performance in US hospitals and compare EST outcomes from higher versus lower volume centers. Methods- Using validated diagnosis codes from data on all discharges from hospitals and Emergency Rooms in Florida (2006-2016) and the National Inpatient Sample (2012-2016) we identified patients with acute ischemic stroke treated with EST. The primary end point was good discharge outcome defined as discharge to home or acute rehabilitation facility. Multivariate regressions adjusted for medical comorbidities, intravenous tPA (tissue-type plasminogen activator) usage and annual hospital stroke volume were used to evaluate the likelihood of good outcome over time and by annual hospital EST volume. Results- A total of 3890 patients (median age, 73 [61-82] years, 51% female) with EST were identified in the Florida cohort and 42 505 (median age, 69 [58-79], 50% female) in the National Inpatient Sample. In both Florida and the National Inpatient Sample, the number of hospitals performing EST increased continuously. Increasing numbers of EST procedures were performed at lower annual EST volume hospitals over the studied time period. In adjusted multivariate regression, there was a continuous increase in the likelihood of good outcomes among patients treated in hospitals with increasing annual EST procedures per year (odds ratio, 1.1; 95% CI, 1.1-1.2 in Florida and odds ratio, 1.3; 95% CI, 1.2-1.4 in National Inpatient Sample). Conclusions- Analysis of population-level datasets of patients treated with EST from 2006 to 2016 demonstrated an increase in the number of centers performing EST, resulting in a greater number of procedures performed at lower volume centers. There was a positive association between EST volume and favorable discharge outcomes in EST-performing hospitals.
背景与目的- 最近的一些具有里程碑意义的试验为血管内卒中治疗(EST)的有效性提供了压倒性的证据。然而,这些试验对临床实践的影响以及低容量中心 EST 的有效性仍知之甚少。在这里,我们确定了美国医院中 EST 性能的人群水平模式,并比较了高容量中心和低容量中心的 EST 结果。
方法- 使用来自佛罗里达州医院和急诊室(2006-2016 年)和国家住院样本(2012-2016 年)所有出院数据的经过验证的诊断代码,我们确定了接受 EST 治疗的急性缺血性卒中患者。主要终点是良好的出院结果,定义为出院回家或急性康复设施。使用多变量回归来调整医疗合并症、静脉内 tPA(组织型纤溶酶原激活物)使用情况和医院每年的卒中量,以评估随时间推移和每年医院 EST 量的良好结果的可能性。
结果- 在佛罗里达州队列中,共确定了 3890 例接受 EST 治疗的患者(中位数年龄 73[61-82]岁,51%为女性),在国家住院样本中确定了 42505 例(中位数年龄 69[58-79]岁,50%为女性)。在佛罗里达州和国家住院样本中,进行 EST 的医院数量都在不断增加。在研究期间,每年进行 EST 手术的医院数量不断增加,而每年的 EST 手术量较低。在调整后的多变量回归中,随着每年接受 EST 治疗的患者数量的增加,患者获得良好结局的可能性也在不断增加(佛罗里达州的优势比为 1.1;95%可信区间为 1.1-1.2,国家住院样本中的优势比为 1.3;95%可信区间为 1.2-1.4)。
结论- 对 2006 年至 2016 年接受 EST 治疗的患者的人群水平数据集进行分析表明,进行 EST 的中心数量有所增加,导致较低容量中心进行的手术数量增加。在进行 EST 的医院中,EST 量与良好的出院结局之间存在正相关关系。